Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) announced a quarterly dividend on Friday, February 7th,RTT News reports. Stockholders of record on Friday, February 21st will be given a dividend of 0.20 per share on Friday, March 7th. This represents a $0.80 annualized dividend and a dividend yield of 2.01%. The ex-dividend date is Friday, February 21st.
Bath & Body Works has increased its dividend by an average of 21.1% per year over the last three years. Bath & Body Works has a dividend payout ratio of 20.0% meaning its dividend is sufficiently covered by earnings. Research analysts expect Bath & Body Works to earn $3.65 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 21.9%.
Bath & Body Works Stock Performance
NYSE:BBWI opened at $39.89 on Wednesday. The company has a market capitalization of $8.64 billion, a price-to-earnings ratio of 9.73, a price-to-earnings-growth ratio of 0.88 and a beta of 1.83. Bath & Body Works has a one year low of $26.20 and a one year high of $52.99. The stock has a 50-day simple moving average of $37.60 and a 200 day simple moving average of $33.72.
Wall Street Analyst Weigh In
A number of analysts have weighed in on BBWI shares. Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th. TD Cowen boosted their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a report on Thursday, December 12th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Argus reissued a “hold” rating on shares of Bath & Body Works in a research note on Friday, January 10th. Finally, JPMorgan Chase & Co. upgraded shares of Bath & Body Works from a “neutral” rating to an “overweight” rating and raised their price target for the company from $41.00 to $47.00 in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Bath & Body Works presently has a consensus rating of “Moderate Buy” and an average target price of $43.56.
Get Our Latest Analysis on Bath & Body Works
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- Are Penny Stocks a Good Fit for Your Portfolio?
- Moderna: A Generational Opportunity for Investors in 2025
- What is the Nasdaq? Complete Overview with History
- Buffett Just Dumped His S&P 500 Holdings—What It Means for You
- How to Evaluate a Stock Before Buying
- General Motors: Can It Survive Tariffs and Loss of EV Mandates?
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.